Ashley Cordova

Ashley Cordova

Former Chief Executive OfficeratNovoCure· In proxies 2021–2025

Pay in FY2025+117% from the year before · NovoCure stock -56.6% the same year

Ashley Cordova was paid $13.2M in FY2025 (Dec), up 117%. NovoCure stock fell 56.6% that year.

Pay$100 in the stock at the end of FY20 → $7
Pay is from the Summary Compensation Table of each NovoCure proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovoCurePublic company · 5 yr
    • Former Chief Executive Officer2021 – Present · 5 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?